A cross-sectional study of the association between the 1-hr oral glucose tolerance test and the metabolic syndrome in a high-risk sample with impaired fasting glucose
Endocrine Practice, Ahead of Print.
Publication date: Available online 26 February 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Awadhesh Kumar Singh, Ritu Singh
Publication date: Available online 26 February 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Mina Movahedian, Jessica Thomas, Jamal Rahmani, Cain C.T. Clark, Bahram Rashidkhani, Matin Ghanavati
Publication date: July 2019Source: Biomedical and Environmental Sciences, Volume 32, Issue 7Author(s): Xue Yan WU, Lin LIN, Qi Hong Yan, Rui DU, Chun Yan HU, Li Na MA, Kui PENG, Mian LI, Yu XU, Min XU, Yu Hong CHEN, Jie Li LU, Yu Fang BI, Wei Qing WANG, Guang NING
AbstractPurpose of ReviewThe epidemiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) is continuously evolving with an increasing life span and the prevalence of metabolic diseases, including obesity, diabetes, cardiovascular disease, and hypertension. As a result, there is a substantial financial strain on health care.Recent FindingsRecent studies and clinical trials have strengthened the relationship of known risk factors of BPH and LUTS. These include metabolic syndrome, diabetes, obesity, hypertension, and elevated serum dihydrotestosterone. Excessive consumption of red meat, saturated...
(Natural News) The World Health Organization (WHO) defines overweight or obesity as the abnormal or excessive accumulation of fat that presents a health risk. Obesity is caused by either one of two things: genetics or an increased consumption of high-calorie foods coupled with a sedentary lifestyle. People with obesity suffer from abnormalities characteristic of metabolic syndrome...